Lack of proteasome active site allostery as revealed by subunit-specific inhibitors - PubMed (original) (raw)
Lack of proteasome active site allostery as revealed by subunit-specific inhibitors
J Myung et al. Mol Cell. 2001 Feb.
Free article
Abstract
The chymotrypsin-like (CT-L) activity of the proteasome is downregulated by substrates of the peptidyl-glutamyl peptide hydrolyzing (PGPH) activity. To investigate the nature of such interactions, we synthesized selective alpha',beta'-epoxyketone inhibitors of the PGPH activity. In cellular proliferation and protein degradation assays, these inhibitors revealed that selective PGPH inhibition was insufficient to inhibit protein degradation, indicating that the CT-L and PGPH sites function independently. We also demonstrated that CT-L inhibition by a PGPH substrate does not require the occupancy of the PGPH site or hydrolysis of the PGPH substrate. Thus, these results support a model in which a substrate of one subunit regulates the activity of another via binding to a noncatalytic site(s) rather than through binding to an active site.
Similar articles
- Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones.
Elofsson M, Splittgerber U, Myung J, Mohan R, Crews CM. Elofsson M, et al. Chem Biol. 1999 Nov;6(11):811-22. doi: 10.1016/s1074-5521(99)80128-8. Chem Biol. 1999. PMID: 10574782 - Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone.
McCormack TA, Cruikshank AA, Grenier L, Melandri FD, Nunes SL, Plamondon L, Stein RL, Dick LR. McCormack TA, et al. Biochemistry. 1998 May 26;37(21):7792-800. doi: 10.1021/bi980097q. Biochemistry. 1998. PMID: 9601040 - Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20 S proteasome.
Schmidtke G, Emch S, Groettrup M, Holzhutter HG. Schmidtke G, et al. J Biol Chem. 2000 Jul 21;275(29):22056-63. doi: 10.1074/jbc.M002513200. J Biol Chem. 2000. PMID: 10806206 - Molecular shredders: how proteasomes fulfill their role.
Groll M, Clausen T. Groll M, et al. Curr Opin Struct Biol. 2003 Dec;13(6):665-73. doi: 10.1016/j.sbi.2003.10.005. Curr Opin Struct Biol. 2003. PMID: 14675543 Review. - Proteinase families and their inhibitors.
Mykles DL. Mykles DL. Methods Cell Biol. 2001;66:247-87. doi: 10.1016/s0091-679x(01)66012-6. Methods Cell Biol. 2001. PMID: 11396006 Review. No abstract available.
Cited by
- Site-Specific Proteasome Inhibitors.
Kisselev AF. Kisselev AF. Biomolecules. 2021 Dec 31;12(1):54. doi: 10.3390/biom12010054. Biomolecules. 2021. PMID: 35053202 Free PMC article. Review. - A Machine Learning Approach for Tracing Tumor Original Sites With Gene Expression Profiles.
Liang X, Zhu W, Liao B, Wang B, Yang J, Mo X, Li R. Liang X, et al. Front Bioeng Biotechnol. 2020 Nov 24;8:607126. doi: 10.3389/fbioe.2020.607126. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 33330438 Free PMC article. - The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.
Tundo GR, Sbardella D, Santoro AM, Coletta A, Oddone F, Grasso G, Milardi D, Lacal PM, Marini S, Purrello R, Graziani G, Coletta M. Tundo GR, et al. Pharmacol Ther. 2020 Sep;213:107579. doi: 10.1016/j.pharmthera.2020.107579. Epub 2020 May 19. Pharmacol Ther. 2020. PMID: 32442437 Free PMC article. - [Research progress on selective immunoproteasome inhibitors].
Kong L, Lu J, Zhu H, Zhang J. Kong L, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019 Dec 25;48(6):688-694. doi: 10.3785/j.issn.1008-9292.2019.12.15. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019. PMID: 31955545 Free PMC article. Review. Chinese. - Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic Modality.
Chamberlain PP, D'Agostino LA, Ellis JM, Hansen JD, Matyskiela ME, McDonald JJ, Riggs JR, Hamann LG. Chamberlain PP, et al. ACS Med Chem Lett. 2019 Nov 12;10(12):1592-1602. doi: 10.1021/acsmedchemlett.9b00425. eCollection 2019 Dec 12. ACS Med Chem Lett. 2019. PMID: 31857833 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources